Loading…
Concomitant Cell Growth and Differentiation are Dependent on ErbB1 and Integrin Activation in an Autonomously Surviving Colon Adenocarcinoma: Involvement of Autocrine Amphiregulin Secretion
In normal colon epithelium, cell proliferation is followed by cell differentiation. The purpose of this work was to investigate, in the HT29-D4 colon adenocarcinoma cell line, the occurrence of a temporal sequence of changes in cell proliferation and differentiation, the role of autocrine EGF family...
Saved in:
Published in: | Anticancer research 2006-07, Vol.26 (4B), p.2769-2783 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In normal colon epithelium, cell proliferation is followed by cell differentiation. The purpose of this work was to investigate,
in the HT29-D4 colon adenocarcinoma cell line, the occurrence of a temporal sequence of changes in cell proliferation and
differentiation, the role of autocrine EGF family ligands and to determine which transduction pathway(s) are involved in these
processes. In a medium lacking both growth factor and serum, HT29-D4 cells secreted amphiregulin (AR), which was shown to
be strongly involved in cell adhesion, growth and differentiation. In the main, integrins α2β1 and αvβ6 intervened in these
processes. Using tyrphostins, it was demonstrated that AR involvement was mediated through the ErbB1/ERK1,2 and ErbB1/ FAK
pathways. These signalling molecules were directly involved in pRb inhibition and, thus, in cyclin A expression. Concomitantly,
colon differentiation markers were also expressed. Furthermore, terminal cell maturation resulted in a colon absorptive cell
with strong polarisation, the growth of which was inhibited by tyrphostin and an ERK1,2 inhibitor. It was concluded that in
a colon adenocarcinoma, cell proliferation and differentiation can occur concomitantly and that these deregulated processes
are controlled by autocrine secretion through the ErbB1/ERK1,2 and FAK pathways. |
---|---|
ISSN: | 0250-7005 1791-7530 |